Literature DB >> 16299069

1H and 13C-NMR and molecular dynamics studies of cyclosporin a interacting with magnesium(II) or cerium(III) in acetonitrile. Conformational changes and cis-trans conversion of peptide bonds.

Francesca Bernardi1, Elena Gaggelli, Elena Molteni, Elena Porciatti, Daniela Valensin, Gianni Valensin.   

Abstract

Cyclosporin A (CsA) is an important drug used to prevent graft rejection in organ transplantations. Its immunosuppressive activity is related to the inhibition of T-cell activation through binding with the proteins Cyclophilin (Cyp) and, subsequently, Calcineurin (CN). In the complex with its target (Cyp), CsA adopts a conformation with all trans peptide bonds and this feature is very important for its pharmacological action. Unfortunately, CsA can cause several side effects, and it can favor the excretion of calcium and magnesium. To evaluate the possible role of conformational effects induced by these two metal ions in the action mechanism of CsA, its complexes with Mg(II) and Ce(III) (the latter as a paramagnetic probe for calcium) have been examined by two-dimensional NMR and relaxation rate analysis. The conformations of the two complexes and of the free form have been determined by restrained molecular dynamics calculations based on the experimentally obtained metal-proton and interproton distances. The findings here ratify the formation of 1:1 complexes of CsA with both Mg(II) and Ce(III), with metal coordination taking place on carbonyl oxygens and substantially altering the peptide structure with respect to the free form, although the residues involved and the resulting conformational changes, including cis-trans conversion of peptide bonds, are different for the two metals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299069      PMCID: PMC1367286          DOI: 10.1529/biophysj.105.074245

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  21 in total

1.  Isotope-edited NMR of cyclosporin A bound to cyclophilin: evidence for a trans 9,10 amide bond.

Authors:  S W Fesik; R T Gampe; T F Holzman; D A Egan; R Edalji; J R Luly; R Simmer; R Helfrich; V Kishore; D H Rich
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

Review 2.  Cyclosporine.

Authors:  B D Kahan
Journal:  N Engl J Med       Date:  1989-12-21       Impact factor: 91.245

Review 3.  Regulation of the calmodulin-stimulated protein phosphatase, calcineurin.

Authors:  C B Klee; H Ren; X Wang
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

4.  [Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity].

Authors:  A Rüegger; M Kuhn; H Lichti; H R Loosli; R Huguenin; C Quiquerez; A von Wartburg
Journal:  Helv Chim Acta       Date:  1976       Impact factor: 2.164

5.  Structural elements pertinent to the interaction of cyclosporin A with its specific receptor protein, cyclophilin.

Authors:  V L Hsu; S L Heald; M W Harding; R E Handschumacher; I M Armitage
Journal:  Biochem Pharmacol       Date:  1990-07-01       Impact factor: 5.858

Review 6.  Mechanisms of action of cyclosporine.

Authors:  S Matsuda; S Koyasu
Journal:  Immunopharmacology       Date:  2000-05

7.  Studies of the interaction of potassium(I), calcium(II), magnesium(II), and copper(II) with cyclosporin A.

Authors:  Rodney M Cusack; Lisbeth Grøndahl; David P Fairlie; Graeme R Hanson; Lawrence R Gahan
Journal:  J Inorg Biochem       Date:  2003-10-01       Impact factor: 4.155

8.  Solubilization of cyclosporin A.

Authors:  Y Ran; L Zhao; Q Xu; S H Yalkowsky
Journal:  AAPS PharmSciTech       Date:  2001-01-18       Impact factor: 3.246

9.  The structure of the Ce(III)-angiotensin II complex as obtained from NMR data and molecular dynamics calculations.

Authors:  Nicola D'Amelio; Elena Gaggelli; Nicola Gaggelli; Francesca Mancini; Elena Molteni; Daniela Valensin; Gianni Valensin
Journal:  J Inorg Biochem       Date:  2003-06-01       Impact factor: 4.155

10.  Two new cyclosporin folds observed in the structures of the immunosuppressant cyclosporin G and the formyl peptide receptor antagonist cyclosporin H at ultra-high resolution.

Authors:  Brian Potter; Rex A Palmer; Robert Withnall; Terence C Jenkins; Babur Z Chowdhry
Journal:  Org Biomol Chem       Date:  2003-05-07       Impact factor: 3.876

View more
  4 in total

1.  Blood-Brain Barrier Permeability Is Exacerbated in Experimental Model of Hepatic Encephalopathy via MMP-9 Activation and Downregulation of Tight Junction Proteins.

Authors:  Saurabh Dhanda; Rajat Sandhir
Journal:  Mol Neurobiol       Date:  2017-05-18       Impact factor: 5.590

2.  DNA aptamers to human immunodeficiency virus reverse transcriptase selected by a primer-free SELEX method: characterization and comparison with other aptamers.

Authors:  Yi-Tak Lai; Jeffrey J DeStefano
Journal:  Nucleic Acid Ther       Date:  2012-05-03       Impact factor: 5.486

3.  Cyclosporin A: Conformational Complexity and Chameleonicity.

Authors:  Satoshi Ono; Matthew R Naylor; Chad E Townsend; Chieko Okumura; Okimasa Okada; Hsiau-Wei Lee; R Scott Lokey
Journal:  J Chem Inf Model       Date:  2021-10-21       Impact factor: 6.162

Review 4.  Novel formulations for antimicrobial peptides.

Authors:  Ana Maria Carmona-Ribeiro; Letícia Dias de Melo Carrasco
Journal:  Int J Mol Sci       Date:  2014-10-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.